(Q37734268)

22 August 2017

1 reference

title

Immunomodulation by intravenous immunoglobulin: role of regulatory T cells (English)

1 reference

22 August 2017

Shivashankar Othy

2

0 references

Pushpa Hegde

Pushpa Hegde

3

0 references

Mohan S. Maddur

Mohan S Maddur

Sébastien Lacroix-Desmazes

1

0 references

Sébastien Lacroix-Desmazes

5

0 references

Jagadeesh Bayry

Jagadeesh Bayry

6

0 references

Srini V Kaveri

Srini V Kaveri

7

0 references

author name string

Janakiraman Vani

4

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Journal of Clinical Immunology

22 August 2017

published in

1 reference

22 August 2017

volume

30 Suppl 1

1 reference

22 August 2017

page(s)

S4-8

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-010-9394-5

22 August 2017

exact match

0 references

cites work

Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-010-9394-5

Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.

21 January 2018

1 reference

12 December 2020

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.

1 reference

12 December 2020

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

12 December 2020

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

12 December 2020

Natural regulatory T cells: mechanisms of suppression

1 reference

12 December 2020

CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance

1 reference

12 December 2020

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

1 reference

12 December 2020

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

12 December 2020

Tregitopes switch on Tregs

1 reference

12 December 2020

Anti-inflammatory actions of intravenous immunoglobulin

1 reference

12 December 2020

Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation

1 reference

12 December 2020

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

12 December 2020

Autoimmunity: CTLA-4: a key protein in autoimmunity

1 reference

12 December 2020

Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGFbeta gene variants

1 reference

12 December 2020

CD25+CD4+ regulatory T cells in patients with Kawasaki disease.

1 reference

12 December 2020

Regulatory T cells and immune tolerance

1 reference

12 December 2020

Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barré syndrome

1 reference

12 December 2020

Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.

1 reference

12 December 2020

Modulation of the cellular immune system by intravenous immunoglobulin

1 reference

12 December 2020

Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other

1 reference

12 December 2020

Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues

1 reference

12 December 2020

Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes"

1 reference

12 December 2020

Mechanisms of foxp3+ T regulatory cell-mediated suppression

1 reference

12 December 2020

10.1007/S10875-010-9394-5

Identifiers

DOI

1 reference

22 August 2017

1 reference